Literature DB >> 2888454

Increased plasma free cortisol in ocular hypertension and open angle glaucoma.

B Schwartz, G McCarty, B Rosner.   

Abstract

Values of plasma free cortisol (not bound to plasma proteins), total plasma cortisol, and percent free cortisol were determined in normal, ocular hypertensive, and open angle glaucomatous subjects. Median total plasma, plasma free, and percent free cortisol levels were higher in ocular hypertensive and glaucomatous individuals. The most significant differences occurred with percent free cortisol values between normal and glaucomatous subjects. There was a significant positive correlation between percent free cortisol and total cortisol levels in normal subjects only. For subjects with glaucoma and hypertension, the percent free cortisol values were independent of the total cortisol values. Multilinear regression analysis also indicated that besides diagnosis and level of total plasma cortisol, male sex, blood sampling late in the day, and increased diastolic blood pressure were the only variables significantly related to increased values of plasma free cortisol and percent free cortisol. Ocular medication for glaucoma and use of beta-blockers were not found to be significant independent variables in the regression models for either plasma free cortisol or percent free cortisol. These observations further suggest that a disorder of the pituitary adrenal axis and/or a binding of plasma cortisol is associated with ocular hypertension and open angle glaucoma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2888454     DOI: 10.1001/archopht.1987.01060080062029

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  9 in total

Review 1.  Corticosteroids and glaucoma risk.

Authors:  R C Tripathi; S K Parapuram; B J Tripathi; Y Zhong; K V Chalam
Journal:  Drugs Aging       Date:  1999-12       Impact factor: 3.923

Review 2.  Role of the alternatively spliced glucocorticoid receptor isoform GRβ in steroid responsiveness and glaucoma.

Authors:  Ankur Jain; Robert J Wordinger; Thomas Yorio; Abbot F Clark
Journal:  J Ocul Pharmacol Ther       Date:  2014-02-07       Impact factor: 2.671

3.  Spliceosome protein (SRp) regulation of glucocorticoid receptor isoforms and glucocorticoid response in human trabecular meshwork cells.

Authors:  Ankur Jain; Robert J Wordinger; Thomas Yorio; Abbot F Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-21       Impact factor: 4.799

4.  Deprivation and late presentation of glaucoma: case-control study.

Authors:  S Fraser; C Bunce; R Wormald; E Brunner
Journal:  BMJ       Date:  2001-03-17

5.  Dexamethasone Stiffens Trabecular Meshwork, Trabecular Meshwork Cells, and Matrix.

Authors:  Vijay Krishna Raghunathan; Joshua T Morgan; Shin Ae Park; Darren Weber; Brett S Phinney; Christopher J Murphy; Paul Russell
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-07       Impact factor: 4.799

Review 6.  Glucocorticoid therapy and ocular hypertension.

Authors:  Adnan Dibas; Thomas Yorio
Journal:  Eur J Pharmacol       Date:  2016-07-05       Impact factor: 4.432

7.  Genome-wide association study of intraocular pressure identifies the GLCCI1/ICA1 region as a glaucoma susceptibility locus.

Authors: 
Journal:  Hum Mol Genet       Date:  2013-07-07       Impact factor: 6.150

8.  Characterization of rabbit myocilin: Implications for human myocilin glycosylation and signal peptide usage.

Authors:  Allan R Shepard; Nasreen Jacobson; Ruifang Sui; H Thomas Steely; Andrew J Lotery; Edwin M Stone; Abbot F Clark
Journal:  BMC Genet       Date:  2003-04-02       Impact factor: 2.797

9.  The Dark Matter of Vision: In search of a Grand Unifying Theory for Glaucoma.

Authors:  Muneeb A Faiq
Journal:  Oman J Ophthalmol       Date:  2018 May-Aug
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.